POEMs and Tips
From Other Journals
Use of Cholinesterase Inhibitors in Alzheimer's Disease
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2003 May 15;67(10):2203.
Clinical Question: Are cholinesterase inhibitors useful in the treatment of Alzheimer's disease?
Setting: Various (meta-analysis)
Study Design: Meta-analysis of randomized controlled trials
Synopsis: Cholinesterase inhibitors are widely touted as being useful in the treatment of Alzheimer's disease. The authors of this study performed a thorough search of the English and non-English literature, including MEDLINE, PsychINFO, the Cochrane Registry, and collected references from bibliographies of reviews and other articles of interest. A total of 29 randomized, double-blind, placebo-controlled trials of outpatients diagnosed with mild to moderate Alzheimer's disease were included.
Two investigators independently extracted study data. Outcomes were measured with the Neuropsychiatric Inventory (NPI) (0 to 120 points possible) and the Alzheimer's Disease Assessment Scale (ADAS; 0 to 50 points possible). Functional outcomes were measured with instruments evaluating activities of daily living. Compared with patients receiving placebo, those treated with cholinesterase inhibitors improved 1.72 points on the NPI and 0.03 points on the ADAS. Improvements on scales that evaluated activites of daily living also were very minimal (0.1 or less standard deviation from baseline). There was no difference in efficacy among the various medications.
Bottom Line: Cholinesterase inhibitors are unlikely to be of much clinical benefit in the treatment of Alzheimer's disease. More patient-oriented research of long-term outcomes, such as quality of life, caregiver burden, and institutionalization, is needed. (Level of Evidence: 1a-)
Trinh NH, et al. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis. JAMA. January 2003;289:210–6.
Used with permission from Slawson D. Cholinesterase inhibitors only minimally beneficial for Alzheimer Disease. Retrieved March 13, 2003, from: http://www.InfoPOEMs.com.
Want to use this article elsewhere? Get Permissions